Zobrazeno 101 - 110
of 21 588
pro vyhledávání: ''
Autor:
Jeanne S. Mandelblatt, Jinani Jayasekera, Young Chandler, Lawrence H. Kushi, Clyde B. Schechter, Suzanne C. O'Neill, Claudine Isaacs, Allison W. Kurian, Joseph A. Sparano
Publikováno v:
Journal of Clinical Oncology. 39:2893-2902
PURPOSE There is a need for industry-independent decision tools that integrate clinicopathologic features, comorbidities, and genomic information for women with node-negative, invasive, hormone receptor–positive, human epidermal growth factor recep
Autor:
Martin Bornhäuser, Michael Kramer, Jan-Niklas Eckardt, Christian Thiede, Johannes Schetelig, Karsten Wendt, Ulrich Schuler, Frank Kroschinsky, Jan Moritz Middeke, Katja Sockel, Christoph Röllig, Anas Shekh Sulaiman, Sebastian Riechert, Tim Schmittmann
Publikováno v:
Leukemia
The evaluation of bone marrow morphology by experienced hematopathologists is essential in the diagnosis of acute myeloid leukemia (AML); however, it suffers from a lack of standardization and inter-observer variability. Deep learning (DL) can proces
Autor:
Anthony Howell, Eleanor Roberts, William G. Newman, Adam R. Brentnall, Helen Byers, Jack Cuzick, Elaine F. Harkness, Elke M van Veen, D. Gareth Evans, Sacha J Howell
Publikováno v:
International Journal of Cancer. 150:73-79
Polygenic risk scores (PRS) for disease risk stratification show great promise for application in general populations, but most are based on data from individuals of white European origin. We assessed two well validated PRS (SNP18, SNP143) in the Pre
Autor:
Jie Wu, Xiang Li, Dapeng Liu, Hong Ren, Haiming Yang, Xin Sun, Guodong Xiao, Pihua Han, Peili Wang
Publikováno v:
Oncology Research
The aim of this study was to identify a novel cancer stemness-related ceRNA regulatory axis in lung adenocarcinoma (LUAD) via weighted gene coexpression network analysis of a stemness index. The RNA sequencing expression profiles of 513 cancer sample
Autor:
John H. Strickler, Johanna C. Bendell, Samuel J. Klempner, James B. Rottman, Michael H. Kagey, Stacey Stein, Girish S. Naik, Marya F. Chaney, Victoria M. Villaflor, Laura LaNiel Tenner, Cynthia A. Sirard
Publikováno v:
Molecular Cancer Therapeutics. 20:2240-2249
Therapeutic combinations targeting innate and adaptive immunity and predictive biomarkers of response in esophagogastric cancer (EGC) are needed. We assessed safety and clinical utility of DKN-01 (a novel DKK1-neutralizing IgG4 antibody) combined wit
Autor:
Mogens Tornby Stender, Louise Thorlacius-Ussing, Maja Ludvigsen, Henrik Vorum, Bent Honoré, Ole Thorlacius-Ussing
Publikováno v:
Current Issues in Molecular Biology
Volume 43
Issue 2
Pages 74-1056
Ludvigsen, M, Thorlacius-Ussing, L, Vorum, H, Stender, M T, Thorlacius-Ussing, O & Honoré, B 2021, ' Proteomic characterization of colorectal cancer tissue from patients identifies novel putative protein biomarkers ', Current Issues in Molecular Biology, vol. 43, no. 2, pp. 1043-1056 . https://doi.org/10.3390/CIMB43020074
Ludvigsen, M, Thorlacius-Ussing, L, Vorum, H, Stender, M T, Thorlacius-Ussing, O & Honoré, B 2021, ' Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers ', Current issues in molecular biology, vol. 43, no. 2, pp. 1043-1056 . https://doi.org/10.3390/cimb43020074
Current Issues in Molecular Biology, Vol 43, Iss 74, Pp 1043-1056 (2021)
Volume 43
Issue 2
Pages 74-1056
Ludvigsen, M, Thorlacius-Ussing, L, Vorum, H, Stender, M T, Thorlacius-Ussing, O & Honoré, B 2021, ' Proteomic characterization of colorectal cancer tissue from patients identifies novel putative protein biomarkers ', Current Issues in Molecular Biology, vol. 43, no. 2, pp. 1043-1056 . https://doi.org/10.3390/CIMB43020074
Ludvigsen, M, Thorlacius-Ussing, L, Vorum, H, Stender, M T, Thorlacius-Ussing, O & Honoré, B 2021, ' Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers ', Current issues in molecular biology, vol. 43, no. 2, pp. 1043-1056 . https://doi.org/10.3390/cimb43020074
Current Issues in Molecular Biology, Vol 43, Iss 74, Pp 1043-1056 (2021)
Colorectal cancer (CRC) is one of the leading causes of cancer-related death over the world. There is a great need for biomarkers capable of early detection and as targets for treatment. Differential protein expression was investigated with two-dimen
Autor:
Serena K. Wolfe, David J. Beebe, Jamie M. Sperger, Jennifer L. Schehr, Erika Heninger, Toni K. Choueri, Xiao X. Wei, Joshua A. Desotelle, Charlotte N. Stahlfeld, Waddah Arafat, Joshua M. Lang, John A. Steinharter, Hamid Emamekhoo, Rana R. McKay, E. Jason Abel, Anupama Singh, Matthew C. Mannino, Tamara S. Rodems, David J. Niles, Rory M. Bade, Benjamin K. Gibbs
Publikováno v:
Molecular Oncology, Vol 15, Iss 9, Pp 2330-2344 (2021)
Molecular Oncology
Molecular Oncology
Although therapeutic options for patients with advanced renal cell carcinoma (RCC) have increased in the past decade, no biomarkers are yet available for patient stratification or evaluation of therapy resistance. Given the dynamic and heterogeneous
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Cancer
BMC Cancer
Background To develop and validate multivariate models integrating endoscopic biopsy, tumor markers, and CT findings based on late arterial phase (LAP) to predict serosal invasion in gastric cancer (GC). Methods The preoperative differentiation degre
Publikováno v:
Modern Pathology. 34:1738-1749
Invasive stratified mucin-producing carcinoma (ISMC) is a recently described entity of human papillomavirus (HPV)-associated endocervical adenocarcinoma with phenotypic plasticity and aggressive clinical behavior. To identify the cell of origin of IS
Autor:
Wei Jia, Ruiqi Zhang, Xihua Shen, Hong Zou, Zhenzhu Sun, Xin Xiong, Weilin Zhao, Lijuan Pang, Chun Wang, Xinhua Ji, Mei Cui, Lin Tao
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Background The differential diagnosis of endometrial stromal tumor (EST) and uterine cellular leiomyoma (CL) remains a challenge in clinical practice, especially low grade endometrial stromal sarcoma (ESS) and CL, suggesting the need for novel immuno